Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.
Tecentriq (atezolizumab) combined with chemotherapy failed to meet its primary endpoint of progression-free survival — the length of time during and after therapy in which the patient’s disease does not ... Read more
Seattle Genetics’ Tukysa (tucatinib) can now be used in combination with trastuzumab and Xeloda (capecitabine) to treat people with metastatic or inoperable HER2-positive breast cancer following its approval by ... Read more
A tumor suppressor protein called neurofibromin, known to block the cancer-inducing Ras pathway, also was found to interact directly with the estrogen receptor (ER) with mutations in this protein ... Read more
Researchers have mapped, at the single-cell level, the diverse types and arrangements of cells within breast cancer tumors, revealing how genetic changes shape the complex tumor landscape. The findings ... Read more
Women under age 40 who plan to use assisted reproductive technology (ART) should first receive mammogram screenings to detect asymptomatic breast cancers that may potentially get worse with infertility ... Read more